GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 386 filers reported holding GLOBUS MED INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $64 | -99.9% | 862 | +18.9% | 0.00% | – |
| Q3 2022 | $43,000 | -95.0% | 725 | -95.3% | 0.00% | -100.0% |
| Q2 2022 | $861,000 | -27.3% | 15,345 | -4.5% | 0.01% | -16.7% |
| Q1 2022 | $1,185,000 | +2.6% | 16,069 | +0.4% | 0.01% | +20.0% |
| Q4 2021 | $1,155,000 | -5.8% | 16,000 | -0.1% | 0.01% | -16.7% |
| Q3 2021 | $1,226,000 | +2.1% | 16,010 | +3.3% | 0.01% | -14.3% |
| Q2 2021 | $1,201,000 | +27.2% | 15,494 | +1.2% | 0.01% | +16.7% |
| Q1 2021 | $944,000 | -3.4% | 15,311 | +2.1% | 0.01% | -14.3% |
| Q4 2020 | $977,000 | +281.6% | 14,990 | +188.9% | 0.01% | +250.0% |
| Q3 2020 | $256,000 | +884.6% | 5,189 | +868.1% | 0.00% | – |
| Q2 2020 | $26,000 | +8.3% | 536 | -3.4% | 0.00% | – |
| Q1 2020 | $24,000 | +4.3% | 555 | +24.4% | 0.00% | – |
| Q3 2019 | $23,000 | +228.6% | 446 | +154.9% | 0.00% | – |
| Q2 2019 | $7,000 | -84.8% | 175 | -81.3% | 0.00% | -100.0% |
| Q1 2019 | $46,000 | – | 938 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pembroke Management, LTD | 584,085 | $43,379,993 | 4.64% |
| Sterling Investment Advisors, Ltd. | 167,023 | $12,404,798 | 4.44% |
| Ophir Asset Management Pty Ltd | 306,871 | $22,791,309 | 4.38% |
| Godshalk Welsh Capital Management, Inc. | 72,285 | $5,368,607 | 3.92% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 672,400 | $49,939,148 | 3.30% |
| Provident Investment Management, Inc. | 362,745 | $26,941,071 | 3.19% |
| XXEC, Inc. | 97,600 | $7,248 | 2.91% |
| Van Berkom & Associates Inc. | 809,945 | $60,155 | 2.58% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,424,326 | $105,784,692 | 2.38% |
| Seaport Global Advisors, LLC | 7,647 | $567,943 | 1.97% |